Table 1.
Comparison between Enrolled, Consent only and Not Enrolled patients
| Enrolled | Consent only | Not enrolled | p-value | |
|---|---|---|---|---|
| 838 | 289 | 1044 | ||
| Age, mean (SD), years | 63.6 (13.5) | 60.5 (17.1) | 64.7 (16.4) | <0.001 a |
| Gender, n (%), women | 443 (53) | 162 (56) | 591 (57) | 0.25 |
| Symptoms at referral, n (%) | ||||
| Weight loss | 297 (35) | 111 (38) | 346 (33) | 0.23 |
| Pain | 122 (15) | 57 (20) | 161 (15) | 0.11 |
| Suspicion of major illness/cancer | 127 (15) | 5 (2) | 30 (3) | <0.001 c |
| Abnormal blood tests | 106 (13) | 36 (12) | 118 (11) | 0.63 |
| Fatigue | 105 (13) | 40 (14) | 151 (14) | 0.48 |
| Pathological lymph node | 72 (9) | 24 (8) | 71 (7) | 0.31 |
| Anemia | 71 (8) | 28 (10) | 74 (7) | 0.28 |
| Feeling ill | 41 (5) | 16 (6) | 34 (3) | 0.09 |
| Night sweats | 46 (5) | 20 (7) | 43 (4) | 0.12 |
| Loss of appetite/nausea | 35 (4) | 25 (9) | 45 (4) | 0.01a |
| Fever | 34 (4) | 10 (3) | 34 (3) | 0.65 |
| Abdominal disorder | 31 (4) | 18 (6) | 43 (4) | 0.18 |
| Increased contact to health system | 2 (0.2) | 1 (0.3) | 0 | 0.48 |
| Recurrent deep venous thrombosis | 1 (0.1) | 1 (0.3) | 0 | 0.62 |
| Increased use of medication | 0 | 0 | 0 | |
| Other | 177 (21) | 72 (25) | 90 (9) | <0.001 b |
| Cancer diagnosis, n (%) | 188 (22) | 35 (12) | <0.001 a | |
aSignificant difference between enrolled and consent only
bSignificant difference between enrolled and not enrolled
cSignificant difference between enrolled and consent only, and significant difference between enrolled and not enrolled
Significant results are higligthed in bold